Kossin LabsAccelerator Atlas
Find startup programs that fit you and never miss a deadline.
For: startup founders. Accelerators, incubators and fellowships with how much they invest, equity terms (the share of your company they take) and application links.
- 117accelerators, incubators and fellowships
- 71state an investment amount
- 66state equity terms
- 25take no equity
Excel + CSV. One-time payment via Gumroad. 30-day money-back guarantee: email us within 30 days for a full refund, and if any data is wrong or a file doesn't open, we'll fix it.
What's inside
- 117 programs across 13 focus categories, from generalist to AI, climate, bio and fintech.
- Investment amount as stated, plus a numeric max investment column (USD) for sorting.
- Equity taken and deal terms (such as a SAFE, a standard early-stage investment contract, and fees) where published.
- Stage accepted, format, location, program length and cohort timing.
- A deadlines tab with each program's next published application deadline (or rolling, meaning open year-round), and a free / no-equity tab.
- Website, application URL, source URL and a last-verified date (Oct 26, 2026) on every row.
Files: accelerators_v1.xlsx (tabs: README, Directory, By focus, Free / no-equity programs, Upcoming deadlines) and accelerators_v1.csv.
Who it's for
- Founders deciding where to apply and comparing terms side by side.
- Founders looking specifically for programs that take no equity.
- University, ecosystem and community teams that point founders to programs.
Terms are often unpublished: only 71 of 117 programs state an investment amount and 66 state equity terms. We leave those cells blank rather than guess. Deadlines change, so confirm dates on each program's own page before you apply.
All 25 columns
Taken from the dataset's header row.
- ID
- Program name
- Organization
- Focus category
- Focus / industries
- Stage accepted
- Format
- Location(s)
- Investment amount (as stated)
- Investment max (USD, number)
- Equity taken (%)
- Deal terms notes (SAFE / fees)
- Program length
- Cohort timing / batches
- Next application deadline
- Deadline date (ISO / rolling)
- Cohort size
- Notable alumni
- Program type
- Free / no equity (Y/N)
- Contact (published role email or contact page)
- Website
- Application URL
- Source URL(s)
- Last verified
10 real rows
Straight from the free sample file. "not published" means the source page did not state that detail. Deadline columns are in the full file; confirm dates on each program's own page.
| Program | Focus | Stage | Location | Investment (as stated) | Equity taken | No equity? |
|---|---|---|---|---|---|---|
| Conviction Embed | AI | Pre-seed / Seed | San Francisco, CA | $250,000 | Uncapped (no fixed %) | N |
| Prosper HealthTech Accelerator (gener8tor) | Bio / Health | Pre-seed / Seed | Birmingham, AL | $90,000 ($50K equity + optional $40K note) | 5% common (for $50K) | N |
| Activate Fellowship | Deep tech / Hardware | Pre-seed (raised <$2M) | US host communities | $100K/yr stipend + $100K R&D + $12K/yr travel | 0% (zero equity) | Y |
| Northwestern Mutual Accelerator (gener8tor) | Fintech | Seed | Milwaukee, WI | $100,000 | not published | N |
| a16z speedrun | Generalist | Pre-seed / Seed | San Francisco, CA | Up to $1,000,000 | not published | N |
| gener8tor North Dakota Accelerator 2027 | Generalist | Pre-seed / Seed | North Dakota | $100,000 | 7.5% | N |
| MassChallenge | Generalist | Pre-seed to Series A | Boston, MA | not published | 0% (zero equity, zero cost) | Y |
| Techstars Anywhere Accelerator | Generalist | Pre-seed / Seed | Remote (3 offsites in VC hubs) | $220,000 | 5% (common, for the $20K) + uncapped MFN SAFE | N |
| Techstars London Accelerator | Generalist | Pre-seed / Seed | London, UK | $220,000 | 5% (common, for the $20K) + uncapped MFN SAFE | N |
| Y Combinator | Generalist | Idea to Seed | San Francisco, CA | $500,000 | 7% (for $125K) + uncapped MFN SAFE | N |
We plan a monthly re-verification pass, with updates free for buyers. Data compiled from public sources; confirm details with the provider before acting.